CTVA · Insider Trading

Corteva, Inc. Common Stock

Every open-market purchase and sale reported by CTVA officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.

Form 4 Filings
50
most recent
Open-Market Buys
0
code P
Sales
0
code S
Reporting Insiders
23
current holders
CTVA — Recent Form 4 Transactions (latest 2026-10-05)
FiledInsiderRole TypeSharesValue
2026-10-05 Brian Titus See Remarks J −24,398 —
2026-10-05 Luther C Kissam IV Chief Executive Officer J −127,949 —
2026-09-17 Jennifer Amy Johnson SVP, Chief Legal Officer F −446 −$37.19K
2026-09-17 David Paul Johnson EVP, Chief Financial Officer F −8,517 −$689.96K
2026-08-04 Janet Plaut Giesselman Director A +98 +$7.75K
2026-08-04 Christopher J. Policinski Director A +412 +$32.50K
2026-08-04 Nayaki R Nayyar Director A +412 +$32.50K
2026-06-03 Luther C Kissam IV CEO, Crop Protection Business A +24,138 —
2026-05-04 Klaus A Engel Director F −906 −$73.40K
2026-05-04 Janet Plaut Giesselman Director A +95 +$7.75K
2026-05-04 Marcos M Lutz Director F −906 −$73.40K
2026-05-04 Nayaki R Nayyar Director A +401 +$32.50K
2026-04-30 Gregory R Page Director A +3,870 —
2026-04-30 Klaus A Engel Director A +2,350 —
2026-04-30 Jean-Marc Gilson Director A +2,350 —
2026-04-30 Janet Plaut Giesselman Director A +2,350 —
2026-04-30 Karen H. Grimes Director A +2,350 —
2026-04-30 Marcos M Lutz Director A +2,350 —
2026-04-30 Nayaki R Nayyar Director A +2,350 —
2026-04-30 Christopher J. Policinski Director A +2,350 —
2026-04-30 Kerry J Preete Director A +2,350 —
2026-04-30 Pat Ward Director A +2,350 —
2026-04-30 David C Everitt Director A +2,350 —
2026-03-02 Charles V. Magro Chief Executive Officer F −4,958 −$397.23K
2026-03-02 Robert D. King EVP, Crop Protection Business F −574 −$45.99K
2026-03-02 Judd M O'Connor EVP, Seed Business Unit F −188 −$15.06K
2026-03-02 Samuel R Eathington See Remarks F −471 −$37.74K
2026-03-02 Audrey Grimm SVP, Chief People Officer F −285 −$22.83K
2026-03-02 Brian Titus See Remarks F −111 −$8.89K
2026-02-26 Charles V. Magro Chief Executive Officer A +108,376 —
2026-02-26 David Paul Johnson EVP, Chief Financial Officer A +24,112 —
2026-02-26 Samuel R Eathington See Remarks A +14,173 —
2026-02-26 Robert D. King EVP, Crop Protection Business A +15,006 —
2026-02-26 Judd M O'Connor EVP, Seed Business Unit A +14,173 —
2026-02-26 Jennifer Amy Johnson SVP, Chief Legal Officer A +12,922 —
2026-02-26 Audrey Grimm SVP, Chief People Officer A +11,255 —
2026-02-26 Brian Titus See Remarks A +2,085 —
2026-02-24 Charles V. Magro Chief Executive Officer F −6,026 −$459.84K
2026-02-24 Robert D. King EVP, Crop Protection Business F −576 −$43.95K
2026-02-24 Samuel R Eathington See Remarks F −572 −$43.65K
2026-02-24 Audrey Grimm SVP, Chief People Officer F −387 −$29.53K
2026-02-24 Judd M O'Connor EVP, Seed Business Unit F −247 −$18.85K
2026-02-24 Brian Titus See Remarks MIXED −4,132 −$427.70K
2026-02-20 Charles V. Magro Chief Executive Officer F −5,319 −$407.38K
2026-02-20 Robert D. King EVP, Crop Protection Business F −526 −$40.29K
2026-02-20 Judd M O'Connor EVP, Seed Business Unit F −352 −$26.96K
2026-02-20 David Paul Johnson EVP, Chief Financial Officer F −704 −$53.92K
2026-02-20 Samuel R Eathington See Remarks F −524 −$40.13K
2026-02-20 Audrey Grimm SVP, Chief People Officer F −399 −$30.56K
2026-02-20 Brian Titus See Remarks F −113 −$8.65K
CTVA — Current Insider Holders
InsiderRole Shares HeldValue
Charles V. Magro Chief Executive Officer 349,214 $4.38M
Luther C Kissam IV Chief Executive Officer 153,087 $1.92M
Cornel B Fuerer See Remarks 101,641 $1.28M
Samuel R Eathington See Remarks 89,431 $1.12M
David Paul Johnson EVP, Chief Financial Officer 73,625 $924.00K
Gregory R Page Director 69,074 $866.88K
Robert D. King EVP, Crop Protection Business 68,664 $861.74K
Marcos M Lutz Director 63,053 $791.32K
Judd M O'Connor EVP, Seed Business Unit 52,465 $658.44K
Michael O. Johanns Director 45,088 $565.86K
Klaus A Engel Director 40,218 $504.75K
Pat Ward Director 38,433 $482.34K
Lamberto Andreotti Director 37,784 $474.19K
Nayaki R Nayyar Director 36,753 $461.26K
Audrey Grimm SVP, Chief People Officer 34,641 $434.75K
Brian Titus See Remarks 34,462 $432.50K
Kerry J Preete Director 20,967 $263.14K
Janet Plaut Giesselman Director 20,247 $254.11K
David C Everitt Director 19,738 $247.72K
Karen H. Grimes Director 18,272 $229.31K
Jennifer Amy Johnson SVP, Chief Legal Officer 16,849 $211.46K
Christopher J. Policinski Director 2,768 $34.74K
Jean-Marc Gilson Director 2,350 $29.49K
CTVA Insider Trading FAQ
Who are the insiders at CTVA?
23 officers, directors and 10%+ beneficial owners currently report holdings in CTVA via SEC Form 4.
Are CTVA insiders buying or selling?
Across the 50 most recent Form 4 filings for CTVA, 0 were open-market purchases (code P) and 0 were sales (code S). Sales frequently reflect scheduled 10b5-1 plans or tax withholding rather than a view on the stock.
How current is CTVA insider data?
Form 4 must be filed within two business days of the transaction, so this is close to real time. The most recent CTVA filing is dated 2026-10-05.
How to read Form 4 activity

Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.

Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.

Full filing history and per-insider positions are on the CTVA quote page; the site-wide leaderboard is on the insider transactions hub.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.